ArticlePakistan journal of medical sciences

Effects of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeted combined chemotherapy on immune function, tumor markers and oxidative stress in patients with stage IV lung adenocarcinoma.

Yanxiao Kun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.